Literature DB >> 1735769

Effects of gamma-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy.

P Y Wen1, M A Lampson, L A Lampson.   

Abstract

Effects of gamma-interferon (IFN-gamma) on immune parameters in the 9L gliosarcoma model were examined. IFN-gamma increased class I major histocompatibility complex (MHC) expression in 9L cells in vitro. In vivo, intratumor injections of IFN-gamma led to increased numbers of inflammatory cells within the tumor and class II+ mononuclear phagocytes at its periphery, and increased MHC class I or II expression by endothelial and ependymal cells. Class I expression in 9L cells themselves was not increased. This suggests that there may be inhibition of class I induction in vivo for certain cell types, for which immunotherapies based on non-MHC restricted mechanisms may be more effective.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735769     DOI: 10.1016/0165-5728(92)90030-o

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

Review 1.  New animal models to probe brain tumor biology, therapy, and immunotherapy: advantages and remaining concerns.

Authors:  L A Lampson
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

Review 2.  Recent advances in immunobiology of brain tumors.

Authors:  M Tada; N de Tribolet
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

3.  Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma.

Authors:  Johannes E A Wolff; Sabine Wagner; Christiane Reinert; Astrid Gnekow; R-D Kortmann; Joachim Kühl; Stefaan W Van Gool
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

4.  Improved technique for establishing short term human brain tumor cultures.

Authors:  M A Farr-Jones; I F Parney; K C Petruk
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

5.  The detection of CMV pp65 and IE1 in glioblastoma multiforme.

Authors:  Kenneth G Lucas; Lei Bao; Richard Bruggeman; Kimberly Dunham; Charles Specht
Journal:  J Neurooncol       Date:  2010-09-05       Impact factor: 4.130

6.  Intrathecal treatment of C6 glioma leptomeningeal metastasis in Wistar rats with interleukin-2.

Authors:  U Herrlinger; R Buchholz; P Jachimczak; M Schabet
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

7.  Identification of HLA a*0201 glioblastoma multiforme cell lines for immunotherapy by PCR-SSP and DNA sequencing.

Authors:  An-Hua Wu; Walter A Hall; Walter C Low
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

8.  Robust ability of IFN-gamma to upregulate class II MHC antigen expression in tumor bearing rat brains.

Authors:  Tanya Dutta; Alexander Spence; Lois A Lampson
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

Review 9.  Brain tumor immunotherapy: an immunologist's perspective.

Authors:  Lois A Lampson
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

10.  Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.

Authors:  David B Paul; Susana B Read; Nisha V Kulprathipanja; German G Gomez; B K Kleinschmidt-DeMasters; Patric M Schiltz; Carol A Kruse
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.